IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $46,947 | -94.8% | 10,318 | -92.0% | 0.00% | -100.0% |
Q2 2023 | $908,843 | +51.7% | 129,097 | +31.7% | 0.00% | 0.0% |
Q1 2023 | $598,969 | -49.6% | 98,031 | -47.3% | 0.00% | -50.0% |
Q4 2022 | $1,188,252 | +353.5% | 185,955 | +3190.1% | 0.01% | +50.0% |
Q4 2020 | $262,000 | -31.2% | 5,652 | -51.2% | 0.00% | -20.0% |
Q3 2020 | $381,000 | -76.6% | 11,586 | -80.5% | 0.01% | -79.2% |
Q2 2020 | $1,629,000 | +45.2% | 59,339 | +46.4% | 0.02% | -31.4% |
Q4 2019 | $1,122,000 | – | 40,522 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |